Cargando…

Incidence of Pneumocystis Pneumonia in Immunocompromised Patients without Human Immunodeficiency Virus on Intravenous Pentamidine Prophylaxis: A Systematic Review and Meta-Analysis

Background: Trimethoprim-sulfamethoxazole (TMP-SMX) is a first-line Pneumocystis pneumonia (PCP) prophylaxis agent, but monthly intravenous pentamidine (IVP) is used in immunocompromised hosts without human immunodeficiency virus (HIV) infection because IVP is not associated with cytopenia and delay...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Chia-Yu, Ching, Patrick R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144649/ https://www.ncbi.nlm.nih.gov/pubmed/37108861 http://dx.doi.org/10.3390/jof9040406

Ejemplares similares

Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study
por: Awad, Wedad B., et al.
Publicado: (2020)

Cotrimoxazole/pentamidine: Lack of efficacy in Pneumocystis jirovecii pneumonia: case report
Publicado: (2021)

Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis
por: Puing, Alfredo G., et al.
Publicado: (2021)

Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
por: Xue, Ting, et al.
Publicado: (2023)

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients
por: Ibrahim, Atif, et al.
Publicado: (2023)

Is It Possible to Differentiate Pneumocystis jirovecii Pneumonia and Colonization in the Immunocompromised Patients with Pneumonia?
por: Aguilar, Yudy A., et al.
Publicado: (2021)

Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
por: Kuennen, Rebecca A, et al.
Publicado: (2010)

Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia
por: Heffelfinger, James D., et al.
Publicado: (2009)

Simultaneous bilateral pneumothorax in an immunocompromised HIV patient with Pneumocystis jirovecii pneumonia
por: Matesanz López, Cristina, et al.
Publicado: (2018)

Programmed death ligand 1 is overexpressed by neutrophils in the blood of immunocompromised human immunodeficiency virus-negative patients with Pneumocystis jirovecii pneumonia
por: Zhang, Nan-Nan, et al.
Publicado: (2019)

Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia
por: LONG, YINGJIAO, et al.
Publicado: (2014)

Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis
por: Dunbar, Albert, et al.
Publicado: (2020)

Treatment and Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients
por: Smith, Don, et al.
Publicado: (2012)

Pneumocystis jirovecii Pneumonia Prophylaxis for Cancer Patients during Chemotherapy
por: Takeuchi, Kazuto, et al.
Publicado: (2021)

Multiple nodular lesions following Pneumocystis pneumonia in a non‐HIV immunocompromised patient
por: Asakura, Takanori, et al.
Publicado: (2016)

Pneumocystis pneumonia in children – the relevance of chemoprophylaxis in different groups of immunocompromised and immunocompetent paediatric patients
por: Zajac-Spychała, Olga, et al.
Publicado: (2015)

Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients
por: Mu, Xiang-Dong, et al.
Publicado: (2016)

Massive Cavitation by Pneumocystis jirovecii in an Immunocompromised Patient
por: Chaar-Hernandez, Aldair, et al.
Publicado: (2022)

Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE
por: Atkinson, Andrew, et al.
Publicado: (2020)

Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients
por: Sheikholeslami, Maryam Fatemeh, et al.
Publicado: (2013)

Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
por: Mori, Shunsuke, et al.
Publicado: (2015)

1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019)

1251. Prevention of Pneumocystis Pneumonia by Ibrexafungerp in a Murine Prophylaxis Model
por: Borroto-Esoda, Katyna, et al.
Publicado: (2020)

Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis
por: Andreasen, Philip B., et al.
Publicado: (2021)

Late Onset Combined Immunodeficiency Presenting with Recurrent Pneumocystis jiroveci Pneumonia
por: Papakonstantinou, Ilias, et al.
Publicado: (2014)

Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study
por: Gaborit, Benjamin Jean, et al.
Publicado: (2019)

Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised Patients
por: Sarasombath, Patsharaporn T., et al.
Publicado: (2021)

Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients
por: Tang, Guoxing, et al.
Publicado: (2021)

Supplementary Role of Immunological Indicators in the Diagnosis and Prognosis of Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients
por: Cao, Yaoqian, et al.
Publicado: (2022)

Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients
por: Wang, Dongsheng, et al.
Publicado: (2022)

A Case Report of Purtscher-Like Retinopathy Secondary to Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient
por: Bezzina, Alastair David, et al.
Publicado: (2022)

Pneumocystis Pneumonia Mimicking Atypical Pneumonia in a Patient With Human Immunodeficiency Virus Infection
por: Hashimoto, Takehiro, et al.
Publicado: (2022)

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
por: Rabacal, Whitney, et al.
Publicado: (2022)

Pneumocystis jiroveci Pneumonia
por: Haque, Abida K., et al.
Publicado: (2008)

The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models
por: Cushion, Melanie T., et al.
Publicado: (2021)

Nanotechnological approaches for pentamidine delivery
por: Andreana, Ilaria, et al.
Publicado: (2022)

Case Report: Pneumonia in a Patient With Combined Variable Immunodeficiency: COVID-19 or Pneumocystis Pneumonia?
por: Tehrani, Shabnam, et al.
Publicado: (2022)

Diagnosis of Pneumocystis jirovecii pneumonia with serum cell-free DNA in non-HIV-infected immunocompromised patients
por: Wang, Dong, et al.
Publicado: (2017)

Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient
por: Bhat, Pavan, et al.
Publicado: (2020)

Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
por: Maillet, M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o51t54oit40t2j8oqc6p2l8d1b